ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992

California Cancer Research Program Seeks Non-Resident Survivor Reviewers.

May 25, 2001

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

Bush Increase For NIH In Sharp Contrast To Cuts In Health Delivery Programs.

April 6, 2001